Found: 4

Select item for more details and to access through your institution.

  • Combined immune checkpoint blockade as a therapeutic strategy for BRCA1-mutated breast cancer.

    Published in:
    Science Translational Medicine, 2017, v. 9, n. 393, p. 1, doi. 10.1126/scitranslmed.aal4922
    By:
    • Nolan, Emma;
    • Savas, Peter;
    • Policheni, Antonia N.;
    • Darcy, Phillip K.;
    • Vaillant, François;
    • Mintoff, Christopher P.;
    • Dushyanthen, Sathana;
    • Mansour, Mariam;
    • Pang, Jia-Min B.;
    • Fox, Stephen B.;
    • Perou, Charles M.;
    • Visvader, Jane E.;
    • Gray, Daniel H. D.;
    • Loi, Sherene;
    • Lindeman, Geoffrey J.
    Publication type:
    Article

  • Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00728-9
    By:
    • Dushyanthen, Sathana;
    • Zhi Ling Teo;
    • Caramia, Franco;
    • Savas, Peter;
    • Mintoff, Christopher P.;
    • Virassamy, Balaji;
    • Henderson, Melissa A.;
    • Luen, Stephen J.;
    • Mansour, Mariam;
    • Kershaw, Michael H.;
    • Trapani, Joseph A.;
    • Neeson, Paul J.;
    • Salgado, Roberto;
    • McArthur, Grant A.;
    • Balko, Justin M.;
    • Beavis, Paul A.;
    • Darcy, Phillip K.;
    • Loi, Sherene
    Publication type:
    Article

  • Combined PARP and WEE1 inhibition triggers anti-tumor immune response in BRCA1/2 wildtype triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2023, v. 9, n. 1, p. 1, doi. 10.1038/s41523-023-00568-5
    By:
    • Teo, Zhi Ling;
    • O'Connor, Mark J.;
    • Versaci, Stephanie;
    • Clarke, Kylie A.;
    • Brown, Emmaline R.;
    • Percy, Luke W.;
    • Kuykhoven, Keilly;
    • Mintoff, Christopher P.;
    • Savas, Peter;
    • Virassamy, Balaji;
    • Luen, Stephen J.;
    • Byrne, Ann;
    • Sant, Sneha;
    • Lindeman, Geoffrey J.;
    • Darcy, Phillip K.;
    • Loi, Sherene
    Publication type:
    Article

  • Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-21576-8
    By:
    • Vergara, Ismael A.;
    • Mintoff, Christopher P.;
    • Sandhu, Shahneen;
    • McIntosh, Lachlan;
    • Young, Richard J.;
    • Wong, Stephen Q.;
    • Colebatch, Andrew;
    • Cameron, Daniel L.;
    • Kwon, Julia Lai;
    • Wolfe, Rory;
    • Peng, Angela;
    • Ellul, Jason;
    • Dou, Xuelin;
    • Fedele, Clare;
    • Boyle, Samantha;
    • Arnau, Gisela Mir;
    • Raleigh, Jeanette;
    • Hatzimihalis, Athena;
    • Szeto, Pacman;
    • Mooi, Jennifer
    Publication type:
    Article